Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-azd-2_10-cv-01736/USCOURTS-azd-2_10-cv-01736-0/pdf.json

Nature of Suit Code: 365
Nature of Suit: Personal Injury - Product Liability
Cause of Action: 28:1332 Diversity-Product Liability

---

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

WO

NOT FOR PUBLICATION

IN THE UNITED STATES DISTRICT COURT

FOR THE DISTRICT OF ARIZONA

IN RE: Zicam Cold Remedy Marketing,

Sales Practices, and Products Liability

Litigation.

_________________________________

THIS DOCUMENT RELATES TO:

Hernandez, Benny D. v. Matrixx

Initiatives, Inc., et al.

CV 10-1752-PHX-GMS

Reynolds, Catherine v. Matrixx

Initiatives, Inc., et al.

CV 10-1750-PHX-FJM

Williams, Linda A. v. Matrixx

Initiatives, Inc., et al.

CV 10-1736-PHX-MEA

)

)

)

)

)

)

)

)

)

)

)

)

)

)

)

)

)

)

)

)

)

)

No. 09-md-2096-PHX-FJM

ORDER

The court has before it the parties’ “Stipulated Motion to Transfer Related Cases to

MDL No. 2096 In Re: Zicam Cold Remedy Marketing, Sales Practices, and Products

Liability Litigation” (doc. 855). We also have motions to reassign from each of the three

individual plaintiffs (docs. 691, 697, and 698).

Plaintiffs allege that they suffered anosmia after using Zicam Cold Remedy, and assert

claims for fraud, negligence, failure to warn, defective design, breaches of express and

implied warranty, and violation of the Unfair and Deceptive Trade Practices Act. Plaintiffs’

Case 2:10-cv-01736-FJM Document 14 Filed 09/16/10 Page 1 of 2
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

- 2 -

cases involve the same defendants and call for determination of substantially the same

questions of law as the other personal injury cases in the MDL. See LRCiv 42.1(a). 

Therefore, IT IS ORDERED GRANTING the parties’ stipulated motion to transfer

(doc. 855). IT IS ORDERED that CV 10-1752-PHX-GMS, CV 10-1750-PHX-FJM, and

CV 10-1736-PHX-MEA shall be transferred to In Re: Zicam Cold Remedy Marketing, Sales

Practices, and Products Liability Litigation, MDL 09-2096-PHX-FJM. We therefore deny

as moot the motions to reassign from the three plaintiffs (docs. 691, 697, and 698).

DATED this 15th day of September, 2010.

Case 2:10-cv-01736-FJM Document 14 Filed 09/16/10 Page 2 of 2